Skip to content

Clinical trials

Terminated Phase 2 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Status: Terminated Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20042
20062
20077
20085
20094
20104
20114
20124
20132
20142
20152
20163
20174
20187
20194
20202
20216
20227
20235
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated83

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)9
University of Texas Southwestern Medical Center3
Assistance Publique - Hôpitaux de Paris2
New Mexico Cancer Research Alliance2
Seoul National University Hospital2
Abramson Cancer Center at Penn Medicine1
Academic and Community Cancer Research United1
Aiwu Ruth He, MD1
Alaunos Therapeutics1
Alliance for Clinical Trials in Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular83
Liver Neoplasms17
Bile Duct Neoplasms7
Gallbladder Neoplasms6
Neoplasms5
Cholangiocarcinoma4
Colorectal Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Neoplasm Metastasis3
Pancreatic Neoplasms3

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.